A new trading day began on Friday, with DarioHealth Corp (NASDAQ: DRIO) stock price up 6.74% from the previous day of trading, before settling in for the closing price of $0.65. DRIO’s price has ranged from $0.63 to $2.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 44.85% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 41.97%. With a float of $29.80 million, this company’s outstanding shares have now reached $31.32 million.
In an organization with 276 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 39.9%, operating margin of -257.9%, and the pretax margin is -97.14%.
DarioHealth Corp (DRIO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of DarioHealth Corp is 22.38%, while institutional ownership is 21.01%. The most recent insider transaction that took place on Nov 12 ’24, was worth 4,546. In this transaction Chief Commercial Officer of this company bought 5,000 shares at a rate of $0.91, taking the stock ownership to the 55,000 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Chief Commercial Officer bought 5,000 for $0.84, making the entire transaction worth $4,221. This insider now owns 45,000 shares in total.
DarioHealth Corp (DRIO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 41.97% per share during the next fiscal year.
DarioHealth Corp (NASDAQ: DRIO) Trading Performance Indicators
Here are DarioHealth Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of DarioHealth Corp (DRIO)
Let’s dig in a bit further. During the last 5-days, its volume was 3.89 million. That was better than the volume of 2.17 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.02%. Additionally, its Average True Range was 0.19.
During the past 100 days, DarioHealth Corp’s (DRIO) raw stochastic average was set at 6.86%, which indicates a significant increase from 6.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 359.47% in the past 14 days, which was higher than the 156.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7967, while its 200-day Moving Average is $1.0806. However, in the short run, DarioHealth Corp’s stock first resistance to watch stands at $0.7393. Second resistance stands at $0.7845. The third major resistance level sits at $0.8242. If the price goes on to break the first support level at $0.6544, it is likely to go to the next support level at $0.6147. The third support level lies at $0.5695 if the price breaches the second support level.
DarioHealth Corp (NASDAQ: DRIO) Key Stats
With a market capitalization of 26.64 million, the company has a total of 34,096K Shares Outstanding. Currently, annual sales are 20,350 K while annual income is -59,430 K. The company’s previous quarter sales were 7,420 K while its latest quarter income was -12,330 K.
